Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment. It’s the first new class of pain ...
Vertex Pharmaceuticals (VRTX) swung to profitability as the company left behind five years of annual earnings declines ...
It's the first new class of pain treatment approved in more than 20 years, Vertex says. Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday's market open after the Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback